8.39
price up icon1.82%   0.15
after-market Dopo l'orario di chiusura: 8.39
loading

Ars Pharmaceuticals Inc Azioni (SPRY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
13.58%
28.09
32.50 7.973 86.58 2.068
Operating Expenses
18.84%
69.55
85.69 45.15 39.38 23.82
Benefits Costs and Expenses
255.66
- - 80.86 -
Costs And Expenses
28.25%
61.48
85.69 45.15 28.02 23.82
Depreciation and Amortization
0.417
- 0.28 - 0.10
Operating Income/Loss
22.05%
-41.47
-53.19 -37.18 47.20 -21.75
Income/Loss From Continuing Operations Before Tax
800.19%
-227.57
32.50 7.973 5.718 2.068
Income/Loss From Continuing Operations After Tax
19.21%
-41.32
-51.15 -33.94 49.93 -19.13
Net Income/Loss
19.21%
-41.32
-51.15 -33.94 49.93 -19.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.84%
0.1537
98.81 98.06 0.1538 97.03
Diluted Average Shares
99.84%
0.1537
98.81 98.06 5.608 97.03
Basic Earnings Per Share
19.23%
-0.42
-0.52 -0.35 0.51 -0.20
Diluted Earnings Per Share
19.23%
-0.42
-0.52 -0.35 0.51 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):